Arm Pain Post-Injection: Likely Causes

Primary Causes: Typical Local Reactions

Pain at the injection site is the most common post-injection adverse event, reported in 65-78% of vaccine recipients and up to 50% of corticosteroid injection patients, according to the American Academy of Pediatrics 1, 2, 3
Moderate to severe pain occurs in 16-18% of patients receiving vaccines, as recommended by the Centers for Disease Control and Prevention 1, 3
The mechanism of pain involves local reactions resulting from immune response to injected antigens, tissue trauma from needle insertion, and irritant properties of the injectate, as stated by the American Academy of Pediatrics 1, 2
Higher allergen concentration, injection volume, and number of antigens increase local reaction rates, according to the Journal of Allergy and Clinical Immunology 6, 7
Glycerin preservatives in concentrations above 30% correlate with increased injection pain, particularly when total glycerin dose exceeds 0.05 mL, as reported by the Journal of Allergy and Clinical Immunology 6, 7

Nerve compression syndromes may develop, as documented in one case of radiating neck and arm pain with nerve compression diagnosed 12 days post-vaccination, according to the Centers for Disease Control and Prevention 2

Vasovagal reactions occur in 2.5% of patients, manifesting as dizziness, syncope, pain, and erythema at injection site, as stated by the American Academy of Pediatrics 1, 4, 5
Facial flushing and sweating occur in 1.6-2.3% of corticosteroid injections, typically resolving within 24-48 hours, according to Praxis Medical Insights 4, 5
Hyperglycemia affects diabetic patients and requires glucose monitoring for 1-3 days post-injection, as recommended by Praxis Medical Insights 5

Evaluate for immediate reactions including vasovagal symptoms, anaphylaxis risk, or acute neurological deficits, as recommended by the American Academy of Pediatrics and the Centers for Disease Control and Prevention 1, 2
Assess for signs of infection, particularly in immunosuppressed patients, according to Praxis Medical Insights 4, 5
Overlooking immunosuppressed status increases risk of serious infectious complications, as stated by Praxis Medical Insights 4, 5